Year-over-year earnings per share growth for the last twelve months: Standard BioTools Inc. (LAB)
The mass cytometry ecosystem ensures Standard BioTools Inc. (LAB) total B2B customer loyalty and FDA support. The quarterly EPS growth rate clearly demonstrates market cycle phases, with the indicator reaching 53.40. Despite fierce patent battles and the risk of product obsolescence, the company maintains its status as a technological leader by investing billions in precision genomics equipment.
Comprehensive metric breakdowns and analytics for Standard BioTools Corp (LAB)
- market value and analyst target forecast:
- company stock exchange capitalization indicators:
- book capitalization data:
- debt level and financial liquidity data:
- earnings and valuation multiples information:
LAB - Company Profit|Future Profit Standard BioTools Inc.|LAB - Company Value to Net Income|Forward P/E Multiple Fluidigm|LAB - Price/Earnings to Growth Ratio|EV/EBITDA Multiple Fluidigm|LAB - Operating income before deduction of amortization|Earnings per share for the last twelve months Standard BioTools|LAB - Net earnings per one share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months fluidigm.com|LAB - Net earnings per one share growth for the current year|Net earnings per share growth forecast for next year Standard BioTools Inc.
Summary company analysis:Standard BioTools - LAB
The quarterly EPS growth vector reflects the integration efficiency of Standard BioTools Inc. (LAB) regarding the development of precision medicine. This indicator measures the dynamics of net income per share, confirming the fundamental resilience of the business. The calculation is based on a comparison of the current quarterly result with the same period last year. A positive trend signals the scaling of bioanalytical technologies. The steady growth of this metric justifies the long-term holding of the asset in a portfolio.
Competitor analysis
Agilent (A) - Year-over-year earnings per share growth for the last twelve months|DGX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Illumina Corp|Exact Sciences Inc. (EXAS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months RVTY (Revvity, Inc.)|Year-over-year earnings per share growth rate for the last twelve months BIO|Quarterly EPS earnings growth NNNN (Anbio)|Quarterly EPS earnings growth Sotera Health Corp SHC|QDEL - Year-over-year earnings per share growth for the last twelve months|OPK (OPKO Health Corp.) - Year-over-year earnings per share growth for the last 12 months|CDNA: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months MRVI|FLGT (Fulgent Genetics) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Cytek Biosciences Inc|Year-over-year earnings per share growth for the last twelve months OraSure Technologies Inc (OSUR)|XGN (exagen.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth MDXH (MDxHealth SA)|LUCD: Year-over-year earnings per share growth for the last 12 months|PRE: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months IMDX (Insight Molecular Diagnostics)|TRIB: Quarterly EPS earnings growth|PRPH (ProPhase Labs Corp) - Year-over-year earnings per share growth for the last twelve months|AIMD (Ainos, Inc.) - Quarterly EPS earnings growth|codiagnostics.com (CODX) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months HeartSciences (HSCS)|BMRA - Earnings per share growth in annualized terms for the last twelve months|Cardio Diagnostics Holdings - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months ONCO (Onconetix Corporation)|VRAX - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months bluejaydx.com|Aspira Women's Health Inc. (AWH) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Accelerate Diagnostics Inc. (AXDX)|Year-over-year earnings per share growth for the last twelve months CENTOGENE|Year-over-year earnings per share growth for the last twelve months ENZ|Year-over-year earnings per share growth for the last twelve months Fresh2 Group Limited (FRES)|Year-over-year net earnings per share change for the last twelve months gtglabs.com|23andMe - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months PMD
